Jin-Ho Jeong
Research Subjects
Jin-Ho Jeong has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ji Hye Hwang
Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University, Seongnam, Republic of Korea
6 shared publications - An Na Kang
Industrial Bio-materials Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea
1 shared publication - Chul Jung
Namsangcheon Korean Medicine Clinic, Seoul, Republic of Korea
1 shared publication - Hyo Won Jung
Department of Herbology, College of Korean Medicine, Dongguk University, Gyeongju 38066, Republic of Korea
1 shared publication - Jaseung Ku
Bogwang Korean Medical Clinic, Seoul, Republic of Korea
1 shared publication - Seok Yong Kang
Korean Medicine R&D Institute, Dongguk University
1 shared publication
Latest Publications
- Open Access
Herbal Medicine Processing By-Products as Bioactive Resources: In Vivo Evidence for Antioxidant, Anti-Inflammatory, and Immunomodulatory Effects
Processing herbal medicine generates substantial quantities of by-products that are discarded as waste. These residues may retain polysaccharides, flavonoids, saponins, terpenoids, and other constituents with pharmacological relevance. This review discusses the bioactive potential of by-products derived from single traditional Chinese and Korean herbal medicines, with emphasis on antioxidant, anti-inflammatory, and immunomodulatory mechanisms documented in preclinical in vivo studies. Representative in vivo evidence suggests that selected residues, marc fractions, fermentation products, and re-extracted by-products were reported to modulate oxidative stress markers, inflammatory cytokines, immune responses, and tissue-protective pathways across diverse experimental models. Processing method appears to be a key determinant of activity, as fermentation, high-temperature/high-pressure treatment, re-extraction, and targeted purification may enhance or diversify residual bioactivity. Current evidence remains limited by inconsistent chemical characterization, heterogeneous animal models, and incomplete reporting of experimental design. Re-evaluating herbal medicine processing by-products as bioactive resources may support sustainable herbal medicine manufacturing and circular bioeconomy frameworks.
Open AccessHerbal Medicine Processing By-Products as Bioactive Resources: In Vivo Evidence for Antioxidant, Anti-Inflammatory, and Immunomodulatory Effects
Processing herbal medicine generates substantial quantities of by-products that are discarded as waste. These residues may retain polysaccharides, flavonoids, saponins, terpenoids, and other constituents with pharmacological relevance. This review discusses the bioactive potential of by-products derived from single traditional Chinese and Korean herbal medicines, with emphasis on antioxidant, anti-inflammatory, and immunomodulatory mechanisms documented in preclinical in vivo studies. Representative in vivo evidence suggests that selected residues, marc fractions, fermentation products, and re-extracted by-products were reported to modulate oxidative stress markers, inflammatory cytokines, immune responses, and tissue-protective pathways across diverse experimental models. Processing method appears to be a key determinant of activity, as fermentation, high-temperature/high-pressure treatment, re-extraction, and targeted purification may enhance or diversify residual bioactivity. Current evidence remains limited by inconsistent chemical characterization, heterogeneous animal models, and incomplete reporting of experimental design. Re-evaluating herbal medicine processing by-products as bioactive resources may support sustainable herbal medicine manufacturing and circular bioeconomy frameworks.
- Open Access
- 22 March 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (4) , 331
Clinical Outcomes of MOK Pharmacopuncture in an Elderly Male Patient with Hypothyroidism—A Case Report and Literature Review
Hypothyroidism is more common in women and individuals between 30 and 50 years old. This case report depicts the clinical outcomes of MOK pharmacopuncture, a type of Korean medicine treatment, for an elderly male patient with hypothyroidism who was on long-term L-thyroxine (LT4) therapy but still felt chronically lethargic and tired and was generally in poor health. A 72-year-old Korean man has been on LT4 since being diagnosed with hypothyroidism 16 years ago and has tried to discontinue hormone supplements in the past. The patient was treated with MOK pharmacopuncture, mainly at the ST10 acupoint, twice a week for four months. Following the treatment, the T3, free-T4, and TPO Ab levels and thyroiditis status on ultrasound showed improvement. Additionally, there were a normalization of ESR levels, an enhancement in the quality of life, a reduction in depression scores, an improvement in the antioxidant status, and an alleviation of major symptoms when compared to pre-treatment conditions. This case report demonstrates the potential of MOK pharmacopuncture as a complementary treatment for an elderly man with hypothyroidism who had a poor quality of life due to fatigue and lethargy despite LT4 treatment.
- 22 March 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (4) , 331
Open AccessClinical Outcomes of MOK Pharmacopuncture in an Elderly Male Patient with Hypothyroidism—A Case Report and Literature Review
Hypothyroidism is more common in women and individuals between 30 and 50 years old. This case report depicts the clinical outcomes of MOK pharmacopuncture, a type of Korean medicine treatment, for an elderly male patient with hypothyroidism who was on long-term L-thyroxine (LT4) therapy but still felt chronically lethargic and tired and was generally in poor health. A 72-year-old Korean man has been on LT4 since being diagnosed with hypothyroidism 16 years ago and has tried to discontinue hormone supplements in the past. The patient was treated with MOK pharmacopuncture, mainly at the ST10 acupoint, twice a week for four months. Following the treatment, the T3, free-T4, and TPO Ab levels and thyroiditis status on ultrasound showed improvement. Additionally, there were a normalization of ESR levels, an enhancement in the quality of life, a reduction in depression scores, an improvement in the antioxidant status, and an alleviation of major symptoms when compared to pre-treatment conditions. This case report demonstrates the potential of MOK pharmacopuncture as a complementary treatment for an elderly man with hypothyroidism who had a poor quality of life due to fatigue and lethargy despite LT4 treatment.
- Open Access
- 25 November 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (47) , e31458
Pharmacopuncture for nerve entrapment syndrome: A protocol for systematic review
Background: Nerve entrapment syndrome occurs when the nerves become compressed or entrapped and restricted. This study aims to evaluate the effectiveness and safety of pharmacopuncture in patients with nerve entrapment syndrome. Methods: A search will be conducted from inception to August 2022 using the following 11 electronic databases: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Allied and Complementary Medicine Database China National Knowledge Infrastructure, and 6 Korean databases. All randomized controlled trials (RCTs) evaluating pharmacopuncture treatment for various nerve entrapment syndromes will be considered, with no restrictions regarding the type of pharmacopuncture solution used. Two reviewers will perform the data extraction and quality assessment using a predefined data extraction form. The methodological quality of the included RCTs will be assessed using the Cochrane risk-of-bias tool. Results: This systematic review will provide high-quality evidence to determine the efficacy and safety of pharmacopuncture therapy for nerve entrapment syndrome. Conclusion: Our findings will be informative for patients with nerve entrapment syndrome, as well as clinicians, policymakers, and researchers.
- 25 November 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (47) , e31458
Open AccessPharmacopuncture for nerve entrapment syndrome: A protocol for systematic review
Background: Nerve entrapment syndrome occurs when the nerves become compressed or entrapped and restricted. This study aims to evaluate the effectiveness and safety of pharmacopuncture in patients with nerve entrapment syndrome. Methods: A search will be conducted from inception to August 2022 using the following 11 electronic databases: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Allied and Complementary Medicine Database China National Knowledge Infrastructure, and 6 Korean databases. All randomized controlled trials (RCTs) evaluating pharmacopuncture treatment for various nerve entrapment syndromes will be considered, with no restrictions regarding the type of pharmacopuncture solution used. Two reviewers will perform the data extraction and quality assessment using a predefined data extraction form. The methodological quality of the included RCTs will be assessed using the Cochrane risk-of-bias tool. Results: This systematic review will provide high-quality evidence to determine the efficacy and safety of pharmacopuncture therapy for nerve entrapment syndrome. Conclusion: Our findings will be informative for patients with nerve entrapment syndrome, as well as clinicians, policymakers, and researchers.
- Open Access
- 30 September 2021
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 24 (3) , 122-137
A Single-Center Retrospective Study on the Effects of Korean Medicine in 342 Traffic Accident Cases
Jin-Ho Jeong, Jaseung Ku, Ji Hye Hwang. J Pharmacopuncture 2021;24:122-37. https://doi.org/10.3831/KPI.2021.24.3.122
- 30 September 2021
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 24 (3) , 122-137
Open AccessA Single-Center Retrospective Study on the Effects of Korean Medicine in 342 Traffic Accident Cases
Jin-Ho Jeong, Jaseung Ku, Ji Hye Hwang. J Pharmacopuncture 2021;24:122-37. https://doi.org/10.3831/KPI.2021.24.3.122
- Open Access
- 27 September 2020
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 37 (3) , 191-197
Korean Medicine Treatment Including Capsaicin-containing (CP) Pharmacopuncture for Acute Low Back and Hip Pain: A Case Report of 3 Patients
Jin-Ho Jeong, Ji Hye Hwang. Korean J Acupunct 2020;37:191-7. https://doi.org/10.14406/acu.2020.020
- 27 September 2020
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 37 (3) , 191-197
Open AccessKorean Medicine Treatment Including Capsaicin-containing (CP) Pharmacopuncture for Acute Low Back and Hip Pain: A Case Report of 3 Patients
Jin-Ho Jeong, Ji Hye Hwang. Korean J Acupunct 2020;37:191-7. https://doi.org/10.14406/acu.2020.020
- Open Access
- 15 December 2017
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 17 (1) , 535
MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
In this study, we evaluated the therapeutic effect of MOK, a pharmacopuncture medicine, on thyroid dysfunction in L-thyroxin (LT4)-induced hyperthyroidism rats. The experimental hyperthyroidism model was prepared by the intraperitoneal injection of LT4 (0.5 mg/kg) once daily for 2 weeks in SD rats. MOK extract was injected at doses of 0.3 or 3 mg/kg on acupuncture points in the thyroid glands of LT4-induced hypothyroidism rats once a day for 2 weeks. The body temperature, body weight, and food/water intake were measured once a week for 2 weeks. The levels of thyroid hormones, total cholesterol, LDL-cholesterol, GOT, and GPT were measured in the sera of rats using ELISA and an automatic blood analyzer. The histological changes of thyroid tissues were observed by H&E staining. The expression of thermo-regulating protein, TRPV1 was determined by western blot in dorsal root ganglion (DRG) and brain tissues. We also measured the contents of GSH in the liver and antioxidant enzymes, SOD, and catalase in the liver, heart, and brain tissues by enzyme-based assay and Western blot, respectively. The acupuncture of MOK extract on the thyroid gland of LT4-induced hyperthyroidism rats significantly decreased the body temperature, and did not change body weight and food and water intakes. MOK acupuncture significantly increased the level of TSH, and decreased the levels of T3 and T4 in hyperthyroidism rats. The expression of TRPV1 was inhibited in both DRG and brain tissues after MOK acupuncture, and the levels of GOT, GPT, total cholesterol, and LDL-cholesterol were also decreased. MOK acupuncture also inhibited the pathological feature with follicular lining epithelial thicknesses and increased follicular colloid depositions in the thyroid glands of hypothyroidism. MOK acupuncture significantly increased hepatic GSH levels and decreased the expression of SOD and catalase in the liver, heart, and brain tissues of hyperthyroidism rats. These results suggest that the pharmacopuncture with MOK extract in hyperthyroidism can improve the pathophysiological changes through regulating the body temperature, thyroid hormones imbalance, lipid accumulation, and oxidation. This anti-hyperthyroidism effect of MOK pharmacopuncture is thought to be related to the control of thermo-regulating protein TRPV1 in DRG and brain.
- 15 December 2017
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 17 (1) , 535
Open AccessMOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
In this study, we evaluated the therapeutic effect of MOK, a pharmacopuncture medicine, on thyroid dysfunction in L-thyroxin (LT4)-induced hyperthyroidism rats. The experimental hyperthyroidism model was prepared by the intraperitoneal injection of LT4 (0.5 mg/kg) once daily for 2 weeks in SD rats. MOK extract was injected at doses of 0.3 or 3 mg/kg on acupuncture points in the thyroid glands of LT4-induced hypothyroidism rats once a day for 2 weeks. The body temperature, body weight, and food/water intake were measured once a week for 2 weeks. The levels of thyroid hormones, total cholesterol, LDL-cholesterol, GOT, and GPT were measured in the sera of rats using ELISA and an automatic blood analyzer. The histological changes of thyroid tissues were observed by H&E staining. The expression of thermo-regulating protein, TRPV1 was determined by western blot in dorsal root ganglion (DRG) and brain tissues. We also measured the contents of GSH in the liver and antioxidant enzymes, SOD, and catalase in the liver, heart, and brain tissues by enzyme-based assay and Western blot, respectively. The acupuncture of MOK extract on the thyroid gland of LT4-induced hyperthyroidism rats significantly decreased the body temperature, and did not change body weight and food and water intakes. MOK acupuncture significantly increased the level of TSH, and decreased the levels of T3 and T4 in hyperthyroidism rats. The expression of TRPV1 was inhibited in both DRG and brain tissues after MOK acupuncture, and the levels of GOT, GPT, total cholesterol, and LDL-cholesterol were also decreased. MOK acupuncture also inhibited the pathological feature with follicular lining epithelial thicknesses and increased follicular colloid depositions in the thyroid glands of hypothyroidism. MOK acupuncture significantly increased hepatic GSH levels and decreased the expression of SOD and catalase in the liver, heart, and brain tissues of hyperthyroidism rats. These results suggest that the pharmacopuncture with MOK extract in hyperthyroidism can improve the pathophysiological changes through regulating the body temperature, thyroid hormones imbalance, lipid accumulation, and oxidation. This anti-hyperthyroidism effect of MOK pharmacopuncture is thought to be related to the control of thermo-regulating protein TRPV1 in DRG and brain.